These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 999970)

  • 21. The use of reno-portal anastomosis in the treatment of portal hypertension: an experimental study.
    Parkinson SW; Summers MB
    Aust N Z J Surg; 1968 Aug; 38(1):70-3. PubMed ID: 5245836
    [No Abstract]   [Full Text] [Related]  

  • 22. [The ammonia tolerance test in intra- and extrahepatic portal vein block].
    Ziegler K
    Dtsch Z Verdau Stoffwechselkr; 1968; 28(2):229-32. PubMed ID: 5732402
    [No Abstract]   [Full Text] [Related]  

  • 23. Noncirrhotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepatic encephalopathy.
    Mínguez B; García-Pagán JC; Bosch J; Turnes J; Alonso J; Rovira A; Córdoba J
    Hepatology; 2006 Apr; 43(4):707-14. PubMed ID: 16557541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Portal venous thrombosis following splenectomy in portal hypertension: risks and management].
    von Flüe M; Rothenbühler JM; Bianchi L; Pippert H; Beglinger C; Harder F
    Schweiz Med Wochenschr; 1993 Dec; 123(49):2309-17. PubMed ID: 8272806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Idiopathic portal hypertension. Diagnostic value of portal vein catheterization (author's transl)].
    Féneyrou B; Pomier-Layrargues G; Mirouze D; Bories P; Jauvion F; Lopez P; Prioton JB; Michel H
    Gastroenterol Clin Biol; 1982 May; 6(5):472-6. PubMed ID: 6980160
    [No Abstract]   [Full Text] [Related]  

  • 26. [Behavior of blood ammonia, insulin, glucagon, renin and prolactin during propranolol therapy in cirrhosis patients with portal hypertension].
    Mazzone O; Randazzo G; Catalano D; Noè I
    Clin Ter; 1986 Jul; 118(2):109-14. PubMed ID: 3527539
    [No Abstract]   [Full Text] [Related]  

  • 27. [Experimental subhepatic portal ypertension. Gastrohepatic repercussion. Cinematographic and biological study].
    Guerrin F; Muh JP; Latrielle JP; Gosselin B; Maillard JP; Ruyant E
    Lille Med; 1972 Apr; 17(4):608-17. PubMed ID: 5066115
    [No Abstract]   [Full Text] [Related]  

  • 28. Restriction of drinking water abrogates splanchnic vasodilation and portal hypertension in portal vein-ligated rats.
    Heinemann A; Schuligoi R; Lippe IT; Stauber RE
    Pharmacology; 2009; 83(1):26-32. PubMed ID: 18987488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The role of cyclooxygenase 2 and prostaglandin I2 in the development of portal hypertensive gastropathy].
    Wu CX; Shi YJ; Liu CA; Gong JP; Li SW
    Zhonghua Gan Zang Bing Za Zhi; 2003 Sep; 11(9):536-8. PubMed ID: 14552713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased plasma volume in two models of portal hypertension in the rat: cirrhosis of the liver and partial portal vein ligation.
    Kravetz D; Arderiu MT; Bosch J; Piera C; Setoain J; Rodés J
    Rev Esp Fisiol; 1987 Jun; 43(2):179-83. PubMed ID: 3659543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid resolution of portal vein thrombosis and noncirrhotic portal hypertension following cyto-reductive therapy in a patient with chronic myeloid leukemia.
    Ince AT; Bölükbaş C; Dalay R; Sökmen HM; Kurdaş OO
    Turk J Gastroenterol; 2003 Jun; 14(2):141-4. PubMed ID: 14614643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Preliminary experimental study on treatment of portal hypertension with auxiliary partial orthotopic liver transplantation].
    Shi LB; Peng CH; Peng SY; Liu YB; He W; Xu B; Chen XP; Bai MD; Wang Y; Tang Z
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Dec; 16(12):730-3. PubMed ID: 15585146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemodynamic changes after ligation of a major branch of the portal vein in rats: comparison with rats with portal vein constriction.
    Um SH; Nishida O; Tokubayashi M; Kimura F; Takimoto Y; Yoshioka H; Inque R; Kita T
    Hepatology; 1994 Jan; 19(1):202-9. PubMed ID: 8276356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of AT II on the exploratory behaviour of rats. Interactions with elymoclavine and bromocryptine.
    Petkova B; Georgiev V; Kambourova T
    Acta Physiol Pharmacol Bulg; 1991; 17(2-3):84-90. PubMed ID: 1819920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical observation on the treatment of portal hypertension by meso-caval shunt, splenectomy plus disconnection of porto-azygos vein (author's transl)].
    Zheng YJ
    Zhonghua Wai Ke Za Zhi; 1981 Sep; 19(9):528-9. PubMed ID: 7338107
    [No Abstract]   [Full Text] [Related]  

  • 36. The effect of 5-hydroxytryptamine given IVC on rat behaviour.
    Drybański Z
    Pol J Pharmacol Pharm; 1975 Oct; 27(Suppl):83-8. PubMed ID: 1208232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Portal hypertension and blood viscosity.
    Sikuler E
    J Clin Gastroenterol; 2007; 41 Suppl 3():S262-5. PubMed ID: 17975475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ammonia tolerance test in liver disease with special reference to non-cirrhotic portal fibrosis.
    Datta DV; Agarwalla ML; Narang AP; Samanta AK; Chhuttani PN
    Indian J Med Res; 1979 Nov; 70():825-32. PubMed ID: 535981
    [No Abstract]   [Full Text] [Related]  

  • 39. Rapid reduction of portal blood ammonia.
    WENDEL OW; BROPHY EM
    Nature; 1961 Feb; 189():404-5. PubMed ID: 13784326
    [No Abstract]   [Full Text] [Related]  

  • 40. [Significance of behabioral parameters in mice in open field (author's transl)].
    Misslin R; Ropartz RB
    Physiol Behav; 1976 Nov; 17(5):767-70. PubMed ID: 1026983
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.